Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease — Stella

Home/Chronic Limb-Threatening Ischemia/Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

View on ClinicalTrials.gov

Recruiting

Back to Chronic Limb-Threatening Ischemia trials

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

United States

NYU Langone Health, New York, New York

CUMC/NYP, New York, New York

Staten Island University Hospital - Northwell Health, Staten Island, New York

Key details

Sponsor

R3 Vascular Inc.

Enrollment target

~300 participants

Started

April 2025

Primary completion

March 2028

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.